29.01.2013 Aufrufe

Von der Apotheke zum Weltmarktführer - Vetter im ... - Vetter Pharma

Von der Apotheke zum Weltmarktführer - Vetter im ... - Vetter Pharma

Von der Apotheke zum Weltmarktführer - Vetter im ... - Vetter Pharma

MEHR ANZEIGEN
WENIGER ANZEIGEN

Sie wollen auch ein ePaper? Erhöhen Sie die Reichweite Ihrer Titel.

YUMPU macht aus Druck-PDFs automatisch weboptimierte ePaper, die Google liebt.

After the turn of the millennium, <strong>Vetter</strong>’s grew and changed<br />

steadily. In accordance with the pharmacist Helmut <strong>Vetter</strong>’s<br />

farsighted vision, the company went from being a contract<br />

manufacturer to a full-service provi<strong>der</strong> for innovative pharmaceutical<br />

and biotechnology companies around the globe.<br />

Even after Helmut <strong>Vetter</strong>’s death, the spirit of the foun<strong>der</strong><br />

still lives on within the entire company. In the late 1990s,<br />

while he was still at the helm, the company business managers<br />

mapped out the »Mission 2000+« based on <strong>Vetter</strong>’s visions<br />

and principles. The mission’s main objective was to develop the<br />

company into a full-service provi<strong>der</strong>. It was to become a partner<br />

to innovative pharmaceutical manufacturers from all over the<br />

world. The goal was for <strong>Vetter</strong> to offer its customers comprehensive<br />

support in the aseptic filling of their drugs into end-user<br />

friendly injection systems.<br />

Looking back at the developments in the pharmaceutical<br />

industry and at the growth of biotechnology around the turn of<br />

the millennium, this proved to be a farsighted strategic direction.<br />

From its relative infancy in the early 1990s, biotechnology<br />

spent a decade adding more and more successes to its credit and<br />

today it is one of the largest forces for growth within the industry.<br />

Biotechnologically manufactured substances have opened<br />

new doors in the treatment of such illnesses as cancer and<br />

multiple sclerosis. Because most of these are parenteral drugs –<br />

in other words they are only administered by injection – there<br />

has been a steady growth in the demand for prefilled injection<br />

systems for these substances. In setting itself up early on to provide<br />

full service in the aseptic filling of syringes and cartridges,<br />

<strong>Vetter</strong> was opt<strong>im</strong>ally prepared to profit from biotechnology’s<br />

triumphal march.<br />

76 …

Hurra! Ihre Datei wurde hochgeladen und ist bereit für die Veröffentlichung.

Erfolgreich gespeichert!

Leider ist etwas schief gelaufen!